Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a pioneer in the development of targeted radiotherapies, today announced it has entered into an agreement for the supply ...

Telix states its automated and high-throughput generator can produce sufficient lead-212 elution for up to 60 clinical doses, ...

The film discusses the groundbreaking development of radioisotopes in medicine, beginning with the first sustained nuclear reaction in 1942. It details the production and application of isotopes, ...

According to Telix Pharmaceuticals, the product has a longer shelf-life (up to 6 hours) and an extended distribution radius compared with other gallium-based products.

The solution is technology developed in the 1960s based on scientific principles discovered two centuries ago: radioisotope thermoelectric generators, or RTGs. RTGs are essentially nuclear-powered ...

Meanwhile, radioisotope copper-64 ... to help see the tumor and help physicians to determine the best course of therapy," says study co-author Afsaneh Lavasanifar, professor in the Faculty ...

Right parotid sialogram. Patient received radioactive iodine therapy 17 months ago and has recently developed obstructive parotid symptomatology. Arrow indicates duct stricture with proximal duct ...